Adaptimmune Therapeutics plc
USD0.05
-0.00 (-3.00%)
CEO
Adrian G. Rawcliffe
IPO Date
2015-05-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$0.04
Prev. Close
$0.05
Day Low
$0.04
Day High
$0.06
52W Low
$0.02
52W High
$0.86
Market Cap
$0.08B
Volume
1.68M
| 96,000 |
| $0.01 |
| 29 Aug 2025 | Bertrand William C JR | Chief Operating Officer | S-Sale | Disposed | 207,000 | $0.01 |
| 19 Aug 2025 | Behbahani Ali | director | S-Sale | Disposed | 4,828,206 | $0.01 |
| 19 Aug 2025 | Behbahani Ali | director | S-Sale | Disposed | 14,671,794 | $0.01 |
| 30 Jul 2025 | EcoR1 Capital, LLC | 10 percent owner | S-Sale | Disposed | 33,931,740 | $0.11 |
| 30 Jul 2025 | EcoR1 Capital, LLC | 10 percent owner | S-Sale | Disposed | 2,687,460 | $0.10 |
| 30 Jul 2025 | EcoR1 Capital, LLC | 10 percent owner | S-Sale | Disposed | 27,433,338 | $0.10 |
| 20 Feb 2025 | Bertrand William C JR | Chief Operating Officer | A-Award | Acquired | 1,612,032 | $0.10 |
| 20 Feb 2025 | Bertrand William C JR | Chief Operating Officer | A-Award | Acquired | 1,074,696 | $0.00 |